---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-037818"
form_type: "8-K"
ticker: "PIII"
cik: "0001832511"
company_name: "P3 Health Partners Inc."
filed_at: "2023-11-08T23:59:59+00:00"
generated_at: "2026-06-08T10:39:24.008097+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# P3 Health Partners Q3 revenue $288.4M (+16% YoY); net loss narrows; guides for positive 2024 Adj EBITDA

## Summary
- Q3 total revenue $288.4M, up 16% YoY; net loss $37.3M vs. $65.3M loss prior year.
- Adjusted EBITDA loss $22.3M, improved from $40.3M loss YoY; medical margin $36.2M, +306%.
- YTD total revenue $919.5M (+16%); net loss $117.3M vs. $1,029.2M loss (incl. $851M goodwill impairment).
- Reaffirms FY 2023 guidance: revenue $1.2B-$1.25B, Adj EBITDA loss $(50)-$(30)M; MA members 115k-120k.
- Preliminary FY 2024 Adj EBITDA guidance of +$20M to +$40M, signaling expected profitability.

## SEC filing metadata
- accession: 0001628280-23-037818
- form_type: 8-K
- ticker: PIII
- cik: 0001832511
- company_name: P3 Health Partners Inc.
- filed_at: 2023-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832511/000162828023037818/0001628280-23-037818-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832511/000162828023037818/piii-20231108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-037818
- JSON: https://secwatch.observer/filing/0001628280-23-037818.json
- Plain text: https://secwatch.observer/filing/0001628280-23-037818.txt

## Key facts
- Earnings Releases
  P3 Health Partners Inc. reported three and nine months ended September 30, 2023 results: revenue $288.4 million, net income Net loss was $37.3 million. Guidance reaffirmed.
  - Period: three and nine months ended September 30, 2023
  - Revenue: $288.4 million
  - Net income: Net loss was $37.3 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: preliminary 2024 full-year Adjusted EBITDA guidance of $20 million to $40 million,” said Dr. Sherif Abdou, CEO of P3. Third-Quarter 2023 Financial Results • Total revenue was $288.4 million, an increase of 16% compared to $248.3 million in the third quarter of the prior year. Net loss was $37.3 million, an increase of approximately 43% compared to a net loss of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832511/000162828023037818/0001628280-23-037818-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.